PA-BENTLEY-SYSTEMS
2.12.2021 22:03:09 CET | Business Wire | Press release
Bentley Systems, Incorporated (Nasdaq:BSY), the infrastructure engineering software company, today announced the winners of the 2021 Going Digital Awards in Infrastructure . The annual awards program recognizes the extraordinary work of Bentley software users advancing infrastructure design, construction, and operations throughout the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211202005219/en/
Sixteen independent jury panels selected the 57 finalists from nearly 300 nominations submitted by more than 230 organizations from 45 countries encompassing 19 categories. To see the Going Digital Awards in Infrastructure finalists present their projects, click here .
Bentley Systems showcased 19 Going Digital Awards in Infrastructure winners on December 2 during the 2021 Year in Infrastructure and Going Digital Awards virtual event. On the previous day at the virtual event, 22 Founders’ Honorees were recognized, representing organizations or individuals whose undertakings contribute notably to infrastructure advancement and/or environmental/social development goals.
The winners of the 2021 Going Digital Awards in Infrastructure are:
Bridges
New York State Department of Transportation
East 138th Street over the Major Deegan Expressway
New York City, New York, United States
Buildings and Campuses
Volgogradnefteproekt, LLC
High-tech Multifunctional Medical Complex
Yukki, St. Petersburg, Russia
Digital Cities
Hubei International Logistics Airport Co., Ltd., Shenzhen S.F. Taisen Holdings (Group) Co., Ltd., Airport Construction Engineering Co., Ltd.
Ezhou Huahu Airport Project
Ezhou, Hubei, China
Digital Construction
Clark Construction Group, LLC
SeaTac Airport International Arrivals Facility
Seattle, Washington, United States
Geotechnical Engineering
China Water Resources Beifang Investigation, Design and Research Co. Ltd.
Geological Survey of Water Conservancy and Hydropower Engineering
Tibet, China
Land and Site Development
Liaoning Water Conservancy and Hydropower Survey and Design Research Institute Co., Ltd.
Dongtaizi Reservoir Project
Chifeng, Inner Mongolia, China
Manufacturing
WISDRI Engineering & Research Incorporation Limited
Converter-based Continuous Casting Project of Jinnan Steel Phase II Quwo Base Capacity Reduction and Replacement Project
Quwo, Shanxi, China
Mining and Offshore Engineering
Polyus
Construction of the Blagodatnoye Mill-5
Krasnoyarsk, Krasnoyarsk Krai, Russia
Power Generation
Capital Engineering and Research Incorporation Ltd.
The World’s First 60MW Subcritical Blast Furnace Gas Power Generation Project
Changshu, Jiangsu, China
Project Delivery Information Management
Mott MacDonald Systra JV with Balfour Beatty Vinci
HS2 Phase 1 Main Civil Construction Works
London, United Kingdom
Rail and Transit
Network Rail + Jacobs
Transpennine Route Upgrade
Manchester/Leeds/York, United Kingdom
Reality Modeling
HDR
Diablo Dam Digital Twin Modeling
Whatcom County, Washington, United States
Road and Rail Asset Performance
Collins Engineers, Inc.
Stone Arch Bridge Rehabilitation
Minneapolis, Minnesota, United States
Roads and Highways
PT Hutama Karya (Persero)
Trans Sumatera Toll Road Project Section Serbelawan-Pematangsiantar
Pematangsiantar, Sumatera Utara, Indonesia
Structural Engineering
HDR and the PennFIRST Team
The Pavilion at Penn Medicine
Philadelphia, Pennsylvania, United States
Utilities and Communications
PowerChina Hubei Electric Engineering Co., Ltd.
Suixian and Guangshui 80MWp Ground-based Photovoltaic Power Project of Hubei Energy Group
Guangshui, Hubei, China
Utilities and Industrial Asset Performance
Canadian Energy Company
Asset Data Lifecycle Program
Fort McMurray, Alberta, Canada
Water and Wastewater Treatment Plants
Larson & Toubro Construction
Khatan Group of Villages Water Supply Scheme (Surface Water Treatment), UP, India
Khatan, Uttar Pradesh, India
Water, Wastewater and Stormwater Networks
Companhia Águas de Joinville (CAJ)
Contingency Plan to Ensure Supply in the Event of Drought (Joinville-Santa Catarina)
Joinville, Santa Catarina, Brazil
The students winning the Future Infrastructure Star Challenge are:
Judge’s Choice Winner
Elif Gungormus Deliismail
Mini-Modular-Plant for Digitized Sustainable Campus
Izmir Institute of Technology, Turkey
People’s Choice Winner
Rodman Raul Cordova Rodriguez
Innovative Dam and Hydroelectric Project
Pontifical Catholic University of Rio de Janeiro, Brazil
To view the project descriptions and access the images, visit the Going Digital Awards in Infrastructure webpage. Detailed descriptions of all nominated projects will be published in the print and digital versions of Bentley’s 2021 Infrastructure Yearbook in early 2022. To review the past editions of this publication, access Bentley’s Infrastructure Yearbooks .
Watch the executive sessions and the Going Digital Awards finalists’ presentations from the 2021 Year in Infrastructure and Going Digital Awards virtual event on-demand here .
# #
About Bentley Systems
Bentley Systems (Nasdaq:BSY) is the infrastructure engineering software
company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, mining, and industrial facilities. Our offerings include MicroStation
-based applications for modeling and simulation, ProjectWise
for project delivery, AssetWise
for asset and network performance, Seequent’s leading geosciences software portfolio, and the iTwin
platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annual revenues of more than $800 million in 172 countries.
© 2021 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, ProjectWise, and Seequent are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005219/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 08:07:00 CET | Press release
The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 08:00:00 CET | Press release
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers a
Bureau Veritas:Sector-Leading Organic Revenue Growth of 6.5% in FY 202525.2.2026 07:30:00 CET | Press release
Strong margin improvement to 16.3% in FY 2025Positive growth outlook with continued margin expansion in 2026New EUR 200 million share buyback Bureau Veritas (BOURSE:BVI): 2025 key figures1 › Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted operating profit of EUR 1,052.9 million, up 5.7% versus EUR 996.2 million in FY 2024, representing an adjusted operating margin of 16.3%, up 32 basis points year-on-year and up 51 basis points at constant currency, › Operating profit of EUR 992.4 million, up 6.3% versus EUR 933.4 million in FY 2024, › Adjusted net profit of EUR 631.4 million, up 1.7% versus EUR 620.7 million in FY 2024, › Adjusted EPS stood at EUR 1.42 in 2025, with a 2.8% increase versus FY 2024 (EUR 1.38 per share) and up 9.2% at constant currency, › Attributable net profit of EUR 588.0 million, up 3.3% versus EUR 569.4 million in FY 2
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 07:00:00 CET | Press release
Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane®syringe for use with a range of Restylane NASHA® lidocaine products in multiple indications in the face and in the hands1-3 Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection comfort and control, helping them deliver consistently premium results 4-7 The syringe’s carton packaging is the first in the industry to be made from 100% recyclable paper, and reaffirms Galderma’s commitment to sustainability and environmental responsibility 8 These approvals demonstrate Galderma’s strong heritage in Injectable Aesthetics, and its commitment to continuing to drive innovation in the field Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-ar
Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 07:00:00 CET | Press release
Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagementResults are published in the 7 January issue of the Journal of Inherited Metabolic DiseaseNizubaglustat is currently in Phase 3 registrational studies in GM1/GM2 gangliosidoses and Niemann-Pick type C disease (NPC) Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom